Capital Performance Advisors’s Chemours CC Stock Holding History

Capital Performance Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3	Closed	-$61	–	597
2024 Q3	$61	Buy	+3	New	+$61	﹤0.01%	2773

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Performance Advisors's CC Position: Q4 2024 in Review

Capital Performance Advisors sold out of Chemours (CC) in Q4 2024, closing a stake of 3 shares — an estimated $61 sold.

Capital Performance Advisors first reported a position in CC in Q3 2024 and held it in 1 quarter. The position peaked at $61 in Q3 2024. 442 funds tracked by Wall St. Rank hold CC as of Q4 2024.

Capital Performance Advisors reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
Capital Performance Advisors sold 3 Chemours shares in Q4 2024, an estimated $61.
Capital Performance Advisors first reported a position in Chemours in Q3 2024 and held it in 1 quarter.
Capital Performance Advisors's Chemours position peaked at $61 in Q3 2024.
442 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.